Management practices for methicillin-resistant staphylococcus aureus bacteremia by adult infectious diseases physicians

Natalie Banniettis, Susan E. Beekmann, Philip M. Polgreen, Shubhi Kaushik, Stephan Kohlhoff, David Gilbert, John E. Bennett, Margaret R. Hammerschlag

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

To assess current use of vancomycin for methicillin-resistant Staphylococcus aureus bacteremia, we surveyed adult infectious disease physicians. Most respondents reported personal experience with infections failing to respond to vancomycin despite minimum inhibitory concentration data indicating susceptibility. In a hypothetical case of such an infection, most would change to daptomycin with or without other agents.

Original languageEnglish (US)
JournalOpen Forum Infectious Diseases
Volume5
Issue number5
DOIs
StatePublished - 2018

Keywords

  • Bacteremia
  • GSSA
  • MRSA
  • Treatment failure
  • Vancomycin

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Management practices for methicillin-resistant staphylococcus aureus bacteremia by adult infectious diseases physicians'. Together they form a unique fingerprint.

  • Cite this

    Banniettis, N., Beekmann, S. E., Polgreen, P. M., Kaushik, S., Kohlhoff, S., Gilbert, D., Bennett, J. E., & Hammerschlag, M. R. (2018). Management practices for methicillin-resistant staphylococcus aureus bacteremia by adult infectious diseases physicians. Open Forum Infectious Diseases, 5(5). https://doi.org/10.1093/ofid/ofy093